VPS9D1 and neoplasm: In xenograft models, VPS9D1-AS1 KO significantly reduced the tumor volumes compared with the controls and significantly decreased the Ki67 and PDL1 levels in xenograft tumors (Figure 3F-H, Figure 3—figure supplement 2I).